Table 2. Pearson’s correlation coefficients between NT-proBNP and hs-TNT and other parameters in patients with light-chain cardiac amyloidosis.
| Variables | NT-proBNP | Hs-TNT | |||
|---|---|---|---|---|---|
| n | P value | n | P value | ||
| Age | −1.116 | ns | −0.001 | ns | |
| eGFR | −0.724 | 0.012 | −0.223 | ns | |
| Hs-TNT | 0.129 | ns | 1 | – | |
| NT-proBNP | 1 | – | 0.129 | ns | |
| IVSd (mm) | −0.077 | ns | −0.351 | ns | |
| LVEF (%) | 0.061 | ns | 0.230 | ns | |
| LAD (mm) | 0.215 | ns | 0.351 | ns | |
| E/E’ | 0.190 | ns | −0.090 | ns | |
| GLS (%) | −0.132 | ns | −0.256 | ns | |
| MRI-LVMI (g/m2) | 0.040 | ns | −0.195 | ns | |
hs-TNT, high sensitive troponin T; NT-proBNP, N-terminal pro-brain natriuretic peptide; eGFR, estimated glomerular filtration rate; LAD, left atrium anteroposterior diameter; LVEF, left ventricular ejection fraction; E’, Tissue Doppler derived early-diastolic mitral annular velocity; LVMI, LV mass indexed to body surface area; GLS, global longitudinal systolic strain; MRI, magnetic resonance imaging; ns, not significant.